Diaceutics PLC (LON:DXRX – Get Free Report) shares dropped 1.6% on Wednesday . The company traded as low as GBX 127 ($1.65) and last traded at GBX 127 ($1.65). Approximately 5,782 shares traded hands during mid-day trading, a decline of 95% from the average daily volume of 111,015 shares. The stock had previously closed at GBX 129 ($1.67).
Analyst Upgrades and Downgrades
Separately, Canaccord Genuity Group reaffirmed a “buy” rating and set a GBX 160 ($2.08) price target on shares of Diaceutics in a report on Tuesday, September 17th.
Read Our Latest Research Report on DXRX
Diaceutics Stock Down 1.6 %
About Diaceutics
Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics.
Read More
- Five stocks we like better than Diaceutics
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- What Do S&P 500 Stocks Tell Investors About the Market?
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Diaceutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diaceutics and related companies with MarketBeat.com's FREE daily email newsletter.